BOZEN, Sud-Tirol, Italy, February 28, 2011 /PRNewswire/ -- Health Robotics today announced that earlier last week, it served proper notice to McKesson of the immediate termination for cause of their exclusive CytoCare distribution and services contract in North America, as well as the termination for cause of their non-exclusive distribution agreement for i.v.STATION and i.v.SOFT within a subset of McKesson Automation's customers.
Health Robotics does not expect this early termination to have a material impact on its overall North American installations given the fact that McKesson's contracts represented less than 10 % of all Health Robotics' contracted installations in the USA and Canada since the companies executed their initial IV Automation agreement in August 2009.
More specifically, i.v.STATION and i.v.SOFT customers should not be disrupted at all by this termination due to the fact that 100% of these installations were contracted for and implemented by non-McKesson Health Robotics' partners and their associates, who will continue to support these i.v.STATION and i.v.SOFT customers without pause.
Until further notice and pending regulatory compliance review, CytoCare customers that have contracts with McKesson Automation should refer their questions about ongoing maintenance and support to McKesson Corporation. Additional non-McKesson CytoCare customers in North America may continue to obtain support from other Health Robotics' channel partners, whose roles may now be expanded as a result of the early termination of the McKesson contract. Health Robotics is committed to quickly reviewing and revamping its channel partner strategy for this complex sector in North America, as well as reaching an agreement with McKesson for the continued support of its customers.
About Health Robotics:
Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing over 175 hospital installations in 5 continents with robotics technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(R) [hazardous IVs], i.v.STATION(R) [non-hazardous IVs], i.v.SOFT(R) [workflow engine for manual compounding], MEDarchiver(R) [life-critical clinical information system], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug and diluent exchange errors, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff. For more information, please visit: http://www.health-robotics.com
For additional information, please contact: Claudia Flaim, Marketing Coordinator [email protected] Phone: +39-0471-200-372
SOURCE Health Robotics